Immunoassays: The Pulse of Immunology | Estateplanning

Immunoassays have revolutionized the field of immunology, enabling researchers to quantify and characterize immune responses with unprecedented precision. Developed in the 1950s by Rosalyn Yalow and Solomon Berson, the first immunoassay, radioimmunoassay (RIA), paved the way for a plethora of innovative diagnostic techniques, including enzyme-linked immunosorbent assay (ELISA) and chemiluminescent immunoassay (CLIA). With a Vibe score of 8, immunoassays have become a cornerstone of modern medicine, with applications spanning from infectious disease diagnosis to cancer research. However, the field is not without controversy, with debates surrounding the accuracy and reliability of certain immunoassay methods. As the field continues to evolve, with advancements in nanotechnology and artificial intelligence, the future of immunoassays looks promising, with potential applications in personalized medicine and precision diagnostics. According to a study published in the Journal of Immunology, the global immunoassay market is projected to reach $4.5 billion by 2025, with a growth rate of 7.5% per annum.